← Browse by Condition
Medical Condition

alzheimer s disease

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2, Phase 2
NCT06508268
Recruiting

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Enrollment
208 pts
Location
Netherlands
Sponsor
Hanze University of Applied Sc...
View Trial →
NCT04820127
Recruiting

Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources Use

Enrollment
668 pts
Location
France
Sponsor
University Hospital, Toulouse
View Trial →
NCT06584357
Recruiting

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Enrollment
1,200 pts
Location
United States, Canad...
Sponsor
GAP Innovations, PBC
View Trial →
NCT05462106 Phase 1, Phase 2
Recruiting

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Enrollment
176 pts
Location
United States, Spain...
Sponsor
AC Immune SA
View Trial →
NCT07402356
Recruiting

VR Pupillometry in Cognitive Impairment

Enrollment
140 pts
Location
Germany
Sponsor
Max-Planck-Institute of Psychi...
View Trial →
NCT06199037 Phase 2
Recruiting

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Enrollment
45 pts
Location
China
Sponsor
Shanghai Hengrui Pharmaceutica...
View Trial →
NCT05655195
Recruiting

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy

Enrollment
50 pts
Location
United States
Sponsor
Massachusetts Institute of Tec...
View Trial →